This inventor holds 6 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Anygen Co., Ltd., Gwangju Institute of Science and Technology, Chembridge Research Laboratories, Inc.. Active years: 2005-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Gwangju, KR (2005 - 2015)
- Buk-gu Gwangju, KR (2017)
Company Filing History:
3 out of 8 
2 out of 498 
1 out of 1 Years Active: 2005-2017
Title: Yong-Chul Kim: Innovator in Pharmaceutical Chemistry
Introduction
Yong-Chul Kim is a prominent inventor based in Gwangju, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific receptors involved in neurological pain and cancer treatment. With a total of 6 patents, his work has the potential to impact the medical community significantly.
Latest Patents
Among his latest patents is a novel pyridine carboxylic acid-based compound used as a P2X1 and P2X3 receptor antagonist. This compound serves as a powerful antagonist of these receptors, making it a promising candidate for treating or preventing diseases associated with neurological pain and chronic inflammation. Another notable patent involves pheophorbide-α conjugates, which exhibit fluorescence and inhibit the survival of various cancer cells. This composition is particularly useful in photodynamic therapy (PDT) for cancers, as it combines the effects of a photosensitizer and an anticancer drug.
Career Highlights
Yong-Chul Kim has worked with notable organizations such as Anygen Co., Ltd. and the Gwangju Institute of Science and Technology. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research endeavors.
Collaborations
Some of his coworkers include Jung-Hoon Yoon and Thomas Webb. Their collaborative efforts have contributed to the advancement of innovative solutions in pharmaceutical chemistry.
Conclusion
Yong-Chul Kim's work exemplifies the intersection of innovation and practical application in medicine. His patents reflect a commitment to addressing critical health issues through scientific research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile